Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia.

Abstract

There is a need to develop additional effective therapies for ischemic stroke. Nitrones, which were first developed as reactive oxygen species (ROS)-trapping compounds, have been proposed as neuroprotective agents for ischemic stroke, a ROS-related disorder. The previous reported ROS-trapping compound, quinolyl nitrone RP19, is here being assayed to induce neuroprotection to ischemia-reperfusion injury in three experimental ischemia models: (i) oxygen-glucose deprivation (OGD) on primary neuronal cultures; (ii) transient global cerebral ischemia in four-vessel occlusion model; and (iii) transient focal cerebral ischemia in middle cerebral artery occlusion (tMCAO) model. RP19 (50 μM) induced long-term neuroprotection at 5 days of recovery after OGD in primary neuronal cultures, evaluated by cell viability assay, and decreased both ROS formation and lipid peroxidation upon recovery after OGD. Furthermore, treatment of animals with RP19 at the onset of reperfusion after either global or focal ischemia, at the dose range that was demonstrated to be neuroprotective in neuronal cultures, decreased neuronal death and apoptosis induction, reduced the size of infarct, and improved the neurological deficit scores after 48 h or 5 days of reperfusion after ischemia. The molecule proposed, quinolyl nitrone RP19, induced substantial neuroprotection on experimental ischemia in neuronal cells, and against ischemic injury following transient brain ischemia in treated animals. This molecule may have potential therapeutic interest in ischemic stroke and to reduce the reoxygenation-induced injury after induced reperfusion.

• Authors: Maria I Ayuso, Emma Martínez-Alonso, Mourad Chioua, Alejandro Escobar-Peso, Rafael Gonzalo-Gobernado, Joan Montaner, José Marco-Contelles, Alberto Alcázar
• Journal: ACS chemical neuroscience (ACS Chem Neurosci) Vol. 8 Issue 10 Pg. 2202-2213 (10 18 2017) ISSN: 1948-7193 [Electronic] United States
• PMID: 28731692 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Neuroprotective Agents
• Nitrogen Oxides
• Quinolines
• nitrones

Topics

• Animals
• Brain (drug effects, metabolism)
• Brain Ischemia (drug therapy)
• Cell Death (drug effects)
• Disease Models, Animal
• Infarction, Middle Cerebral Artery (drug therapy)
• Neurons (drug effects)
• Neuroprotective Agents (pharmacology)
• Nitrogen Oxides (pharmacology)
• Quinolines (pharmacology)
• Rats, Sprague-Dawley
• Stroke (drug therapy)